Atlas Trials

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

Clinical trial NCT00817206 · COMPLETED

Trial details

NCT number
NCT00817206
Sponsor
Veloxis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Renal Failure
Start date
2008-12-01
Primary completion
2011-02-01
Enrollment
326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.